New UK-based technical innovation facility – building on HORIBA’s global network of customer scientific collaboration sites – opens in Nuneaton on MIRA Tech Park. From left to right: Managing Director of HORIBA MIRA and HORIBA Corporate Officer, Mr. Declan Allen, Envoy Extraordinary and Minister Plenipotentiary of Embassy of Japan, Mr. Masaki Ikegami, British Ambassador to Japan, Her […]

EQT Healthcare Growth to acquire Europa Biosite, a distributor of over ten million high-quality life science reagents to academic and biopharma researchers across Europe and North America, from Adelis Equity EQT will support Europa Biosite’s next phase of growth through commercial excellence initiatives, digital upgrades, expanded product access, and continued M&A, with the company set […]

The new suite extends GMP bioconjugate production for intermediates and active pharmaceutical ingredients from early clinical phase through to late clinical phases and commercial supply. Staad – Biosynth, a leading developer and supplier of critical raw materials and services for life sciences and diagnostics, is pleased to announce the opening of its expanded GMP bioconjugation […]

Amsbio, in association with Nordmark Biochemicals, has expanded its range of Collagenase and Neutral Protease NB enzymes with GMP grade formats and protocols to support advanced tissue dissociation workflows for applications from research to clinical use. These enzymes, derived from Clostridium histolyticum, are critical raw materials for isolating viable cells from complex tissues – an […]

LINCOLN, NE and Heidelberg, Germany – LICORbio, a leading innovator in life science imaging and analytical solutions, today announced the acquisition of SERVA Electrophoresis, a privately held company known for its high-quality electrophoresis reagents, consumables, and workflow instrumentation. The transaction strengthens LICORbio’s position as a comprehensive solutions provider in protein analysis and enhances its commitment to […]

Saint-Germain-en-Laye, France – Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and bioanalytical products. Under this agreement, Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxemburg, Sweden, Switzerland and the United Kingdom. MN’s Bioanalysis […]

Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development and diagnostics The NATO Innovation Fund and Earlybird led a $35 million Series A round in Portal Biotech, a pioneering biotechnology company headquartered in London. This represents one of Europe’s largest investments into a life sciences tools company and positions Portal Biotech […]

Funding to accelerate platform expansion into new applications in cell-to-cell interactions and tissue STOCKHOLM, Sweden — Pixelgen Technologies today announced that it has been awarded grant and equity financing of EUR 12.5 M  ($14.7 million) from the European Innovation Council (EIC) Accelerator, a funding initiative under the European Union’s Horizon Europe program designed to support highly innovative start-ups with […]

WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer. This appointment marks a pivotal step in Danaher’s digital transformation and its ambition to lead the […]

WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025. Mr. Milosevich has served as Vice President and Group Executive of the […]